Nanobac Pharmaceuticals Inc NNBP
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $249.51
- Volume/Avg
- 5,681 / 14,104
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nanobac Pharmaceuticals Inc is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve peoples health through the detection and treatment of Calcifying Nanoparticles.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 10
- Website
- http://www.nanobaclabs.com
Valuation
|
Metric
|
NNBP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NNBP
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
NNBP
|
|---|---|
Return on Assets (Normalized) | −87.53% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −251.02% |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Djlp | $456.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rhtnx | $91.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Rhsbn | $89.8 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Blzgr | $40.2 Bil | |
MRNA
| Moderna Inc | Pck | $29.6 Bil | |
ARGX
| argenx SE ADR | Xhm | $26.4 Bil | |
BNTX
| BioNTech SE ADR | Nxw | $23.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rgbvn | $21.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Tvjppl | $17.2 Bil | |
INCY
| Incyte Corp | Hkpxt | $12.2 Bil |